Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin

Richard M Tempero, Michael A Hollingsworth, Michael D. Burdick, Angela M. Finch, Stephen M. Taylor, Shawn M. Vogen, Edward L. Morgan, Sam D. Sanderson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating Ab responses against peptide epitopes derived from human MUC1 glycoprotein and the human μ and κ opioid receptors. C57BL6 mice were immunized with the MUC1 epitope (YKQGGFLGL); the C5a agonist (YSFKPMPLaR); YSFKPMPLaR and YKQGGFLGL together, but unconjugated; a C5a-active, MUC1 epitope construct (YKQGGFLGLYSFKPMPLaR); and a C5a-inactive, reversed moiety construct (YSFKPMPLaRYKQGGFLGL). High Ab titers specific for the MUC1 epitope were observed only in mice immunized with the C5a-active epitope construct. Similar results were obtained in BALB/c mice immunized with the C5a-active, MUC1 epitope construct. Abs from the sera of the C57BL6 mice were predominately of the IgG2a, IgG2b, and IgM isotypes and were reactive against human recombinant MUC1 and MUC1 expressed by the Panc-1 M1F.15 pancreatic cell line. When compared with the corresponding KLH-epitope conjugates in C57BL6 mice, the epitope-C5a agonist constructs produced titers of specific IgG Abs of isotypes distinct from those generated by the keyhole limpet hemocyanin-epitope conjugates. Rabbits immunized with a μ opioid receptor epitope-C5a agonist construct (GDLSDPCGNRTNLGGRDSLYSFKPMPLaR) or a κ opioid receptor epitope-C5a agonist construct (FPGWAEPDSNGSEDAQLYSFKPMPLaR) generated high titer, epitope-specific Ab responses. Ab titers generated in response to the opioid epitope-C5a agonist constructs were comparable to those generated by the opioid KLH-epitope conjugates. The results of this study are discussed in terms of possible mechanisms by which the conformationally biased C5a agonist serves as a molecular adjuvant.

Original languageEnglish (US)
Pages (from-to)1377-1382
Number of pages6
JournalJournal of Immunology
Volume158
Issue number3
StatePublished - Feb 1 1997

Fingerprint

Anaphylatoxins
Epitopes
Opioid Receptors
Opioid Analgesics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Tempero, R. M., Hollingsworth, M. A., Burdick, M. D., Finch, A. M., Taylor, S. M., Vogen, S. M., ... Sanderson, S. D. (1997). Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin. Journal of Immunology, 158(3), 1377-1382.

Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin. / Tempero, Richard M; Hollingsworth, Michael A; Burdick, Michael D.; Finch, Angela M.; Taylor, Stephen M.; Vogen, Shawn M.; Morgan, Edward L.; Sanderson, Sam D.

In: Journal of Immunology, Vol. 158, No. 3, 01.02.1997, p. 1377-1382.

Research output: Contribution to journalArticle

Tempero, RM, Hollingsworth, MA, Burdick, MD, Finch, AM, Taylor, SM, Vogen, SM, Morgan, EL & Sanderson, SD 1997, 'Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin', Journal of Immunology, vol. 158, no. 3, pp. 1377-1382.
Tempero, Richard M ; Hollingsworth, Michael A ; Burdick, Michael D. ; Finch, Angela M. ; Taylor, Stephen M. ; Vogen, Shawn M. ; Morgan, Edward L. ; Sanderson, Sam D. / Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin. In: Journal of Immunology. 1997 ; Vol. 158, No. 3. pp. 1377-1382.
@article{363f119301df4d17899d19682fdb0e79,
title = "Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin",
abstract = "A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating Ab responses against peptide epitopes derived from human MUC1 glycoprotein and the human μ and κ opioid receptors. C57BL6 mice were immunized with the MUC1 epitope (YKQGGFLGL); the C5a agonist (YSFKPMPLaR); YSFKPMPLaR and YKQGGFLGL together, but unconjugated; a C5a-active, MUC1 epitope construct (YKQGGFLGLYSFKPMPLaR); and a C5a-inactive, reversed moiety construct (YSFKPMPLaRYKQGGFLGL). High Ab titers specific for the MUC1 epitope were observed only in mice immunized with the C5a-active epitope construct. Similar results were obtained in BALB/c mice immunized with the C5a-active, MUC1 epitope construct. Abs from the sera of the C57BL6 mice were predominately of the IgG2a, IgG2b, and IgM isotypes and were reactive against human recombinant MUC1 and MUC1 expressed by the Panc-1 M1F.15 pancreatic cell line. When compared with the corresponding KLH-epitope conjugates in C57BL6 mice, the epitope-C5a agonist constructs produced titers of specific IgG Abs of isotypes distinct from those generated by the keyhole limpet hemocyanin-epitope conjugates. Rabbits immunized with a μ opioid receptor epitope-C5a agonist construct (GDLSDPCGNRTNLGGRDSLYSFKPMPLaR) or a κ opioid receptor epitope-C5a agonist construct (FPGWAEPDSNGSEDAQLYSFKPMPLaR) generated high titer, epitope-specific Ab responses. Ab titers generated in response to the opioid epitope-C5a agonist constructs were comparable to those generated by the opioid KLH-epitope conjugates. The results of this study are discussed in terms of possible mechanisms by which the conformationally biased C5a agonist serves as a molecular adjuvant.",
author = "Tempero, {Richard M} and Hollingsworth, {Michael A} and Burdick, {Michael D.} and Finch, {Angela M.} and Taylor, {Stephen M.} and Vogen, {Shawn M.} and Morgan, {Edward L.} and Sanderson, {Sam D.}",
year = "1997",
month = "2",
day = "1",
language = "English (US)",
volume = "158",
pages = "1377--1382",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Molecular Adjuvant Effects of a Conformationally Biased Agonist of Human C5a Anaphylatoxin

AU - Tempero, Richard M

AU - Hollingsworth, Michael A

AU - Burdick, Michael D.

AU - Finch, Angela M.

AU - Taylor, Stephen M.

AU - Vogen, Shawn M.

AU - Morgan, Edward L.

AU - Sanderson, Sam D.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating Ab responses against peptide epitopes derived from human MUC1 glycoprotein and the human μ and κ opioid receptors. C57BL6 mice were immunized with the MUC1 epitope (YKQGGFLGL); the C5a agonist (YSFKPMPLaR); YSFKPMPLaR and YKQGGFLGL together, but unconjugated; a C5a-active, MUC1 epitope construct (YKQGGFLGLYSFKPMPLaR); and a C5a-inactive, reversed moiety construct (YSFKPMPLaRYKQGGFLGL). High Ab titers specific for the MUC1 epitope were observed only in mice immunized with the C5a-active epitope construct. Similar results were obtained in BALB/c mice immunized with the C5a-active, MUC1 epitope construct. Abs from the sera of the C57BL6 mice were predominately of the IgG2a, IgG2b, and IgM isotypes and were reactive against human recombinant MUC1 and MUC1 expressed by the Panc-1 M1F.15 pancreatic cell line. When compared with the corresponding KLH-epitope conjugates in C57BL6 mice, the epitope-C5a agonist constructs produced titers of specific IgG Abs of isotypes distinct from those generated by the keyhole limpet hemocyanin-epitope conjugates. Rabbits immunized with a μ opioid receptor epitope-C5a agonist construct (GDLSDPCGNRTNLGGRDSLYSFKPMPLaR) or a κ opioid receptor epitope-C5a agonist construct (FPGWAEPDSNGSEDAQLYSFKPMPLaR) generated high titer, epitope-specific Ab responses. Ab titers generated in response to the opioid epitope-C5a agonist constructs were comparable to those generated by the opioid KLH-epitope conjugates. The results of this study are discussed in terms of possible mechanisms by which the conformationally biased C5a agonist serves as a molecular adjuvant.

AB - A conformationally biased decapeptide agonist of human C5a anaphylatoxin (YSFKPMPLaR) was used as a molecular adjuvant in stimulating Ab responses against peptide epitopes derived from human MUC1 glycoprotein and the human μ and κ opioid receptors. C57BL6 mice were immunized with the MUC1 epitope (YKQGGFLGL); the C5a agonist (YSFKPMPLaR); YSFKPMPLaR and YKQGGFLGL together, but unconjugated; a C5a-active, MUC1 epitope construct (YKQGGFLGLYSFKPMPLaR); and a C5a-inactive, reversed moiety construct (YSFKPMPLaRYKQGGFLGL). High Ab titers specific for the MUC1 epitope were observed only in mice immunized with the C5a-active epitope construct. Similar results were obtained in BALB/c mice immunized with the C5a-active, MUC1 epitope construct. Abs from the sera of the C57BL6 mice were predominately of the IgG2a, IgG2b, and IgM isotypes and were reactive against human recombinant MUC1 and MUC1 expressed by the Panc-1 M1F.15 pancreatic cell line. When compared with the corresponding KLH-epitope conjugates in C57BL6 mice, the epitope-C5a agonist constructs produced titers of specific IgG Abs of isotypes distinct from those generated by the keyhole limpet hemocyanin-epitope conjugates. Rabbits immunized with a μ opioid receptor epitope-C5a agonist construct (GDLSDPCGNRTNLGGRDSLYSFKPMPLaR) or a κ opioid receptor epitope-C5a agonist construct (FPGWAEPDSNGSEDAQLYSFKPMPLaR) generated high titer, epitope-specific Ab responses. Ab titers generated in response to the opioid epitope-C5a agonist constructs were comparable to those generated by the opioid KLH-epitope conjugates. The results of this study are discussed in terms of possible mechanisms by which the conformationally biased C5a agonist serves as a molecular adjuvant.

UR - http://www.scopus.com/inward/record.url?scp=0031065195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031065195&partnerID=8YFLogxK

M3 - Article

C2 - 9013982

AN - SCOPUS:0031065195

VL - 158

SP - 1377

EP - 1382

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -